As with most cancers, survival for oesophageal cancer is improving. One-year
Oesophageal Cancer (C15), Age-standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five- and ten-year survival has increased by a lesser amount than one-year survival since the early 1970s. Five-year age-standardised net survival for oesophageal cancer in men has increased from 4% during 1971-1972 to a predicted survival of 16% during 2010-2011 in England and Wales – an absolute survival difference of 11 percentage points.[1] In women, five-year survival has increased from 5% to 15% over the same time period (a difference of 10 percentage points).
Oesophageal Cancer (C15), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five-year survival for 2010-2011 is predicted using an excess hazard statistical model
Ten-year age-standardised net survival for oesophageal cancer in men has increased from 3% during 1971-1972 to a predicted survival of 12% during 2010-2011 in England and Wales – an absolute survival difference of 9 percentage points.[1] In women, ten-year survival has increased from 4% to 13% over the same time period (a difference of 9 percentage points). Overall, more than 1 in 10 people diagnosed with oesophageal cancer today are predicted to survive their disease for at least ten years.
Oesophageal Cancer (C15), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model
About this data
Data is for: England and Wales, 1971-2011, ICD-10 C15